Literature DB >> 31054628

Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.

Bojan Jelaković1, Živka Dika1, Volker M Arlt2, Marie Stiborova3, Nikola M Pavlović4, Jovan Nikolić5, Jean-Marie Colet6, Jean-Louis Vanherweghem7, Joëlle L Nortier8.   

Abstract

Balkan endemic nephropathy is a chronic tubulointerstitial disease with insidious onset, slowly progressing to end-stage renal disease and frequently associated with urothelial carcinoma of the upper urinary tract (UTUC). It was described in South-East Europe at the Balkan peninsula in rural areas around tributaries of the Danube River. After decades of intensive investigation, the causative factor was identified as the environmental phytotoxin aristolochic acid (AA) contained in Aristolochia clematitis, a common plant growing in wheat fields that was ingested through home-baked bread. AA initially was involved in the outbreak of cases of rapidly progressive renal fibrosis reported in Belgium after intake of root extracts of Aristolochia fangchi imported from China. A high prevalence of UTUC was found in these patients. The common molecular link between Balkan and Belgian nephropathy cases was the detection of aristolactam-DNA adducts in renal tissue and UTUC. These adducts are not only biomarkers of prior exposure to AA, but they also trigger urothelial malignancy by inducing specific mutations (A:T to T:A transversion) in critical genes of carcinogenesis, including the tumor-suppressor TP53. Such mutational signatures are found in other cases worldwide, particularly in Taiwan, highlighting the general public health issue of AA exposure by traditional phytotherapies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aristolochia species; Balkan endemic nephropathy; aristolochic acid; aristolochic acid nephropathy; upper tract urothelial carcinoma

Mesh:

Substances:

Year:  2019        PMID: 31054628     DOI: 10.1016/j.semnephrol.2019.02.007

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  12 in total

Review 1.  Genetic diversity assessment and biotechnological aspects in Aristolochia spp.

Authors:  Shreya Nath; Nilanjana Ghosh; Tauhid Alam Ansari; Avinash Mundhra; Manoj Tukaram Patil; Abhijit Mane; Abilash Valsala Gopalakrishnan; Md Habibur Rahman; Manoj Kumar; Mimosa Ghorai; Subhabrata Paul; Abhijit Dey
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-15       Impact factor: 5.560

2.  Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells.

Authors:  Medjda Bellamri; Kyle Brandt; Christina V Brown; Ming-Tsang Wu; Robert J Turesky
Journal:  Arch Toxicol       Date:  2021-05-03       Impact factor: 6.168

Review 3.  Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition.

Authors:  Thomas Baudoux; Inès Jadot; Anne-Emilie Declèves; Marie-Hélène Antoine; Jean-Marie Colet; Olivia Botton; Eric De Prez; Agnieszka Pozdzik; Cécile Husson; Nathalie Caron; Joëlle L Nortier
Journal:  Front Med (Lausanne)       Date:  2022-05-04

4.  The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro.

Authors:  Mateja Sborchia; Eric G De Prez; Marie-Hélène Antoine; Lucie Bienfait; Radek Indra; Gabriel Valbuena; David H Phillips; Joëlle L Nortier; Marie Stiborová; Hector C Keun; Volker M Arlt
Journal:  Arch Toxicol       Date:  2019-10-10       Impact factor: 5.153

5.  Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene TP53 Using Human TP53 Knock-in (Hupki) Mouse Embryo Fibroblasts.

Authors:  Lisa Hölzl-Armstrong; Jill E Kucab; Michael Korenjak; Mirjam Luijten; David H Phillips; Jiri Zavadil; Volker M Arlt
Journal:  Methods Protoc       Date:  2019-11-13

6.  The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo.

Authors:  Mateja Sborchia; Hector C Keun; David H Phillips; Volker M Arlt
Journal:  Int J Mol Sci       Date:  2019-12-06       Impact factor: 5.923

7.  Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.

Authors:  Yu-Chan Kang; Ming-Hong Chen; Chung-Ying Lin; Chih-Yun Lin; Yen-Ta Chen
Journal:  Ther Adv Drug Saf       Date:  2021-03-21

8.  Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines.

Authors:  Suyan Liu; Zhong Xian; Yong Zhao; Lianmei Wang; Jingzhuo Tian; Chen Pan; Jiayin Han; Yushi Zhang; Chunying Li; Yan Yi; Chenyue Liu; Dunfang Wang; Jing Meng; Shasha Qin; Fang Wang; Aihua Liang
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

9.  Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy.

Authors:  Sharad Kholia; Maria Beatriz Herrera Sanchez; Massimo Cedrino; Elli Papadimitriou; Marta Tapparo; Maria Chiara Deregibus; Stefania Bruno; Federica Antico; Maria Felice Brizzi; Peter J Quesenberry; Giovanni Camussi
Journal:  Front Cell Dev Biol       Date:  2020-03-24

Review 10.  Nephrotoxicity of Herbal Medicine and Its Prevention.

Authors:  Xiaofen Xu; Ruyi Zhu; Jialiang Ying; Mengting Zhao; Xin Wu; Gang Cao; Kuilong Wang
Journal:  Front Pharmacol       Date:  2020-10-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.